Senior Manager

press@researchandmarkets.com

Fax from USA: 646-607-1907

Fax from rest of the world: +353-1-481-1716

Research and Markets (http://www.researchandmarkets.com/research/ 8a499a/medicated_skin_car) has announced the addition of the "Medicated Skin Care Products - Global Strategic Business Report" report to their offering.

This report analyzes the worldwide markets for Medicated Skin Care Products in Millions of US$. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia- Pacific, and Latin America. Annual forecasts are provided for each region for the period of 2001 through 2015. A ten-year historic analysis is also provided for these markets with annual market analytics. The report profiles 135 companies including many key and niche players worldwide such as Advanced Research Laboratories, Allergan, Inc., avVaa World Health Care Products, Blistex, Inc., CCA Industries, Inc., Chattem, Inc., Convatec, FNC Medical Corporation, Galderma Pharma SA, Henkel AG & Co. KgaA, Johnson & Johnson, Neutrogena Corp, Novartis AG, Obagi Medical Products, Inc., Procter & Gamble Company, Reckitt Benckiser Plc., Rohto Pharmaceutical, Mentholatum Co., Inc., Stiefel Laboratories, Schering-Plough Corp., Shiseido Co Ltd, Unilever NV, and Wyeth Corp. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

Key Topics Covered:

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

II. Executive Summary

-- Industry Overview & Outlook

-- Market Trends

-- Product Overview

-- Product Launches

-- Recent Industry Activity

-- Focus on Select Players

-- Global Market Perspective

III. MARKET

-- The United States

-- Canada

-- Japan

-- Europe

-- Asia Pacific

-- Latin America

IV. COMPETITIVE LANDSCAPE

For more information visit http://www.researchandmarkets.com/ research/8a499a/medicated_skin_car

(c) 2009 BUSINESS WIRE. Provided by ProQuest LLC. All rights Reserved.

A service of YellowBrix, Inc.